Analysts Rate Piramal Healthcare Best Play On Innovator CRAMS
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Piramal Healthcare was rated by Citigroup Analysts as India's best play on innovator CRAMS, following its FY09 earnings call July 24